Active Ingredient: BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
Proprietary Name: CONTRAVE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 90MG;8MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N200063
Product Number: 001
Approval Date: Sep 10, 2014
Applicant Holder Full Name: NALPROPION PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
